Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation. Earnings and Valuation This table compares Capricor Therapeutics […]
Shares of REGN stock jumped Monday after the Food and Drug Administration approved Regeneron Pharmaceuticals' (REGN) high-dose Eylea following a delay this…